India-EU FTA may lower costs of novel drugs for Indian patients, medical equipment
The deal will reduce tariffs on pharmaceutical exports from Europe to India to zero from 11% for almost all products. This will also reduce input costs for specialized raw material that Indian firms import from Europe.
The deal will reduce tariffs on pharmaceutical exports from Europe to India to zero from 11% for almost all products. This will also reduce input costs for specialized raw material that Indian firms import from Europe.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
